Alright, Ginny & Georgia fans, let’s talk about the big question: Is Season 4 of Ginny & Georgia actually happening? After that wild Season 3 finale on Netflix (June 5, 2025, anyone?), we’re all dying ...

Jefferies reiterated its ‘Buy’ rating on the stock with a target price of ₹100, stating that a higher HRAB could significantly enhance allowable tariff recovery and profitability for DIAL, addressing ...

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd and a leading global biosimilars company, has received marketing authorisation from the European Commission (EC) for its biosimilars Vevzuo® and ...

The hotel is scheduled to open in November 2025 and will be called Garner Hotel Kyoto Shijo Karasuma, following an extensive interior renovation with strong Kyoto design influences. It will be the ...

Founded in 2004, Plasma Services Group has specialized in the collection, screening and supply of high quality and rare biological materials required for R&D and manufacturing in the in vitro ...

Eat Better Co, one of India’s fastest-growing healthy snacking brands, has partnered with Unicommerce, a leading e-commerce enablement platform, to streamline its order processing and warehouse ...

Shares of Adani Enterprises are expected to be in focus following the company’s latest announcement that it has successfully commissioned India’s first 5 MW off-grid green hydrogen pilot plant. The ...

Solar Industries shares were in focus today after the company’s defence subsidiary received an order for 450 units of Nagastra-1R loitering munitions from the Indian Army. As of 11:45 AM, the shares ...

IT stocks witnessed a sharp decline of up to 3% on June 23, after global technology major Accenture narrowed its full-year revenue growth guidance, sparking concerns over demand headwinds in the ...

The report also noted that Kfin Tech’s domestic business remains healthy, with no major pricing pressure, and the company is well positioned to emerge as a global RTA (Registrar and Transfer Agent) ...

Jefferies has maintained a buy rating on Cholamandalam Investment and Finance Company, assigning a target price of ₹1,800 per share, citing long-term structural positives despite near-term headwinds.

CLSA has reiterated its positive outlook on Indian IT services, following Accenture’s decision to raise its FY25 organic growth guidance to 3–4%, citing strong traction in Gen AI, cloud, and digital ...